Lawsuits alleging vision loss from the use of popular weight loss drugs Ozempic, Wegovy, Saxenda, and Trulicity, will be consolidated and transferred to the Eastern District of Pennsylvania. A ruling from the U.S. Judicial Panel on Multidistrict Litigation issued on December 15 states that numerous cases across the country are similar enough that they should be handled by the same judge in federal …
Continue Reading about Ozempic vision loss cases approved for new mass tort proceeding
